View Single Post
  #1 (permalink)  
Old 08-09-2006, 11:47 PM
rjbsec's Avatar
rjbsec rjbsec is offline
Registered User
 
Join Date: Mar 2003
Posts: 38
Thanks: 0
Thanked 1 Time in 1 Post
rjbsec is on a distinguished road
Perioperative use of recombinant activated factor VII in a Jehovah's Witness patient

A case report from one of our local hospitals here in the UK - as much a triumph for getting a UK paper as for the use of Factor 7a !

Quote:
We report the successful use of recombinant activated factor VII (rFVIIa) in a 48-year-old male Jehovah's Witness with rectal bleeding and perioperative hemorrhage associated with sigmoid colectomy. The patient experienced no further blood loss following the administration of rFVIIa, and no adverse events were observed. Our findings suggest that rFVIIa may represent a new therapeutic opportunity for the management of hemorrhage in patients who do not consent to blood transfusions, and that the use of the agent in this patient population is worthy of further investigation.

Blackwell Synergy
Reply With Quote

Welcome!
To see more of this thread, please login or register.